| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO001_SA042_1000aC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO011_SA041_1000cC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO021_SA034_1000eC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO036_SA015_1001bC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO041_SA052_1001dC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO051_SA221_1001fC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO066_SA074_1002bC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO076_SA075_1002dC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO086_SA068_1002fC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO091_SA094_1003aC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO101_SA143_1003cC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO111_SA122_1003eC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO126_SA100_1005bC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO136_SA147_1005dC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO141_SA130_1005fC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO151_SA132_1006aC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO161_SA170_1006cC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO181_SA160_1007aC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO191_SA159_1007cC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO201_SA200_1007eC1 | Phenotype:CF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO002_SA044_1000aC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO012_SA023_1000cC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO022_SA024_1000eC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO037_SA048_1001bC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO042_SA031_1001dC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO052_SA033_1001fC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO067_SA059_1002bC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO077_SA063_1002dC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO087_SA091_1002fC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO092_SA060_1003aC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO102_SA110_1003cC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO112_SA106_1003eC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO127_SA108_1005bC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO137_SA107_1005dC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO142_SA102_1005fC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO152_SA127_1006aC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO162_SA194_1006cC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO182_SA198_1007aC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO192_SA191_1007cC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO202_SA210_1007eC2 | Phenotype:CF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO003_SA011_1000aC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO013_SA007_1000cC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO023_SA012_1000eC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO038_SA008_1001bC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO043_SA003_1001dC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO053_SA028_1001fC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO068_SA082_1002bC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO078_SA067_1002dC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO088_SA064_1002fC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO093_SA092_1003aC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO103_SA150_1003cC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO113_SA134_1003eC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO128_SA152_1005bC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO138_SA145_1005dC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO143_SA124_1005fC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO153_SA138_1006aC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO163_SA184_1006cC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO183_SA195_1007aC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO193_SA177_1007cC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO203_SA199_1007eC3 | Phenotype:CF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO006_SA030_1000bG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO016_SA040_1000dG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO026_SA019_1000fG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO031_SA043_1001aG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO046_SA005_1001eG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO056_SA090_1001gG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO061_SA084_1002aG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO071_SA069_1002cG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO081_SA055_1002eG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO096_SA080_1003bG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO106_SA136_1003dG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO116_SA117_1003fG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO121_SA123_1005aG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO131_SA116_1005cG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO146_SA105_1005gG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO156_SA161_1006bG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO166_SA158_1006dG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO171_SA172_1006eG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO176_SA162_1006fG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO186_SA190_1007bG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO196_SA156_1007dG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO206_SA201_1007fG1 | Phenotype:GF | Collection Time (hours):0-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO007_SA037_1000bG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO017_SA018_1000dG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO027_SA001_1000fG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO032_SA017_1001aG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO047_SA006_1001eG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO057_SA062_1001gG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO062_SA071_1002aG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO072_SA073_1002cG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO082_SA061_1002eG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO097_SA057_1003bG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO107_SA119_1003dG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO117_SA121_1003fG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO122_SA111_1005aG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO132_SA144_1005cG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO147_SA109_1005gG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO157_SA196_1006bG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO167_SA181_1006dG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO172_SA164_1006eG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO177_SA166_1006fG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO187_SA163_1007bG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO197_SA175_1007dG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO207_SA209_1007fG2 | Phenotype:GF | Collection Time (hours):2-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO008_SA020_1000bG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO018_SA022_1000dG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO028_SA009_1000fG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO033_SA045_1001aG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO048_SA010_1001eG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO058_SA097_1001gG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO063_SA095_1002aG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO073_SA065_1002cG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO083_SA099_1002eG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO098_SA076_1003bG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO108_SA148_1003dG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO118_SA113_1003fG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO123_SA115_1005aG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO133_SA112_1005cG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO148_SA131_1005gG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO158_SA155_1006bG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO168_SA157_1006dG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO173_SA171_1006eG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO178_SA182_1006fG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO188_SA192_1007bG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO198_SA176_1007dG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_SO208_SA205_1007fG3 | Phenotype:GF | Collection Time (hours):4-h | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_NIST1 | Phenotype:NIST | Collection Time (hours):NIST | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_NIST2 | Phenotype:NIST | Collection Time (hours):NIST | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_NIST3 | Phenotype:NIST | Collection Time (hours):NIST | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC01 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC02 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC03 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC04 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC05 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC06 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC07 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC08 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC09 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC10 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC11 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC12 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC13 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC14 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC15 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC16 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC17 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC18 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC19 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC20 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC21 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC22 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_QC23 | Phenotype:QC | Collection Time (hours):QC | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep1 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep10 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep2 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep3 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep4 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep5 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep6 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep7 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep8 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
| Reversed phase POSITIVE ION MODE | GLA_TT_Lipids_Rep9 | Phenotype:Rep | Collection Time (hours):Rep | nanograms (absolute) |
Return to study ST000989 main page
Download data matrix(Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|